Genome Express
Meylan
About Genome Express
Genome Express operates as a biotechnology company. It provides DNA synthesis, DNA sequencing, and DNA libraries to pharmaceutical and agro-food companies and academic laboratories. The company develops and markets value-added solutions in functional and exploratory genomics and functional proteomics for discovery processes.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $11.0M
- Funding stage: M&A
- Last round: Series B (Dec 2001)
- Phone: +33456381111
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/genome-express-280907 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.